Pricing, Reimbursement At Center of China Industry Reform Pleas
This article was originally published in PharmAsia News
Executive Summary
Amid widening pessimism, Chinese domestic pharma executives have voiced few signs of relief at an annual "meet the regulators' session in which concerns are aired and candid views shared.